Noninvasix Medical Devices

5 known investors

Noninvasix is developing a patented optoacoustic platform to non-invasively and continuously measure central venous oxygen saturation, an indicator of sepsis and septic shock severity. The system is intended for clinicians in ICU settings to diagnose and monitor tissue hypoxia in critically ill patients, with potential future uses in fetal monitoring, neonatal care, and traumatic brain injury.